BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.49M | -3.44M | -2.99M | -2.21M | -1.84M |
| Total Depreciation and Amortization | 755.10K | 754.10K | 787.70K | 812.40K | 1.14M |
| Total Amortization of Deferred Charges | 40.20K | 40.20K | 40.20K | 40.20K | 43.30K |
| Total Other Non-Cash Items | 41.60K | 76.50K | 200.90K | 173.80K | 88.10K |
| Change in Net Operating Assets | 3.66M | 3.00M | 1.70M | 1.82M | 703.50K |
| Cash from Operations | 1.01M | 432.10K | -255.90K | 631.50K | 137.60K |
| Capital Expenditure | 10.10K | -17.20K | -63.00K | -94.10K | -146.70K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 5.10K | 5.10K | 5.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -23.30K | -50.10K | -66.10K | -66.10K |
| Cash from Investing | 9.20K | -40.50K | -108.00K | -155.10K | -207.70K |
| Total Debt Issued | 525.00K | 761.60K | 736.90K | 736.90K | 789.70K |
| Total Debt Repaid | -403.80K | -259.40K | -552.20K | -606.90K | -591.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -294.70K | -884.50K | -496.90K | -439.30K | -373.50K |
| Cash from Financing | -126.50K | -281.50K | -227.90K | -240.20K | -139.10K |
| Foreign Exchange rate Adjustments | -848.20K | -515.60K | -452.50K | -315.50K | 122.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.70K | -405.40K | -1.04M | -79.40K | -86.40K |
